| Literature DB >> 34206471 |
Agata Leońska-Duniec1, Katarzyna Świtała1, Ildus I Ahmetov2,3, Craig Pickering4, Myosotis Massidda5, Maciej Buryta6, Andrzej Mastalerz7, Ewelina Maculewicz7.
Abstract
The functional FABP2 Ala54Thr polymorphism (rs1799883) is strongly associated with lipid and carbohydrate metabolism, although the function of its potential modifying effect on training-induced changes in obesity-related parameters is still unknown. The aim of the present study was to investigate the influence of the Ala54Thr polymorphism on post-training changes of selected body mass and body composition measurements, as well as with biochemical parameters of energy metabolism. Accordingly, alleles and genotypes distribution in a group of 168 young, nonobese Caucasian women measured for chosen body composition parameters, lipid profile, and glucose levels before and after the completion of a 12-week aerobic training program were studied. Although the obtained results showed changes in body mass, BMI, FM, %FM, FFM, TBW, HDL-C, and glucose levels during the training program, none of the examined parameters changed significantly across the FABP2 genotypes. Instead, we found a main effect of genotype on BMI (p = 0.033), with carriers of the Thr54 allele having a higher BMI during the whole study period compared with the Ala54 carriers. We confirm that the FABP2 Ala54Thr polymorphism may help identify women at risk for overweight and obesity. However, we did not notice evidence of an interaction between physical activity and the Ala54Thr polymorphism on the examined parameters.Entities:
Keywords: FABP2 gene; adaptation; body composition; lipid profile; physical activity; polymorphism; sport genetics
Mesh:
Substances:
Year: 2021 PMID: 34206471 PMCID: PMC8305881 DOI: 10.3390/genes12070954
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Body composition and metabolic parameters before training program initialization.
| Parameter | Pre |
|---|---|
| body mass (kg) | 59.2 (55.2–65.5) |
| BMI (kg/m2) | 21.3 (19.9–22.9) |
| %FM (%) | 24.3 (20.2–28.1) |
| FM (kg) | 14.5 (11.2–17.4) |
| FFM (kg) | 45.4 (43.6–47.6) |
| TBW (kg) | 33.2 (31.8–35.0) |
| TC (mg/dL) | 167.0 (150.5–184.5) |
| TGL (mg/dL) | 73.0 (60.0–92.0) |
| HDL-C (mg/dL) | 64.4 (55.0–73.9) |
| LDL-C (mg/dL) | 87.3 (71.2–103.9) |
| Glucose (mg/dL) | 80.0 (71.0–85.0) |
Median (lower quartile-upper quartile).
The FABP2 genotypes and response to training (2-way repeated measures ANOVA).
| Parameter | Ala54/Ala54 | Ala54/Th54r + Thr54/Thr54 ( | Genotype | Training | Genotype × Training Interaction | ||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post |
|
|
| |
| body mass (kg) | 59.9 ± 7.8 | 59.0 ± 7.6 | 61.4 ± 7.5 | 60.7 ± 7.4 | 0.166 | <0.0001 | 0.583 |
| BMI (kg/m2) * | 21.1 (18.9–23.5) | 20.9 (18.8–23.2) | 21.9 (19.6–24.4) | 21.6 (19.4–24.2) | 0.033 | <0.0001 | 0.954 |
| %FM (%) | 23.3 ± 5.4 | 21.7 ± 5.7 | 24.5 ± 5.4 | 23.4 ± 5.4 | 0.079 | <0.0001 | 0.128 |
| FM (kg) | 14.3 ± 5.1 | 13.2 ± 5.2 | 15.4 ± 5.0 | 14.5 ± 4.9 | 0.124 | <0.0001 | 0.379 |
| FFM (kg) | 45.5 ± 3.2 | 46.0 ± 3.2 | 45.9 ± 3.2 | 46.2 ± 3.3 | 0.465 | 0.00002 | 0.235 |
| TBW (kg) | 33.3 ± 2.8 | 33.8 ± 2.4 | 33.6 ± 2.4 | 33.8 ± 2.4 | 0.589 | 0.002 | 0.318 |
| TC (mg/dL) | 170 ± 26 | 166 ± 26 | 170 ± 23 | 171 ± 28 | 0.514 | 0.380 | 0.068 |
| TGL (mg/dL) * | 75.9 (52.6–109.7) | 77.4 (52.1–115.2) | 74.1 (52.4–104.9) | 79.2 (58.4–107.3) | 0.719 | 0.175 | 0.847 |
| HDL-C (mg/dL) | 63.7 ± 12.1 | 59.2 ± 12.9 | 66.6 ± 14.5 | 63.3 ± 13.9 | 0.063 | 0.000005 | 0.436 |
| LDL-C (mg/dL) | 90.2 ± 23.3 | 89.9 ± 23.5 | 87.2 ± 20.5 | 91.3 ± 23.7 | 0.798 | 0.218 | 0.147 |
| Glucose(mg/dL) | 78.1 ± 10.2 | 74.9 ± 9.7 | 78.3 ± 9.4 | 76.2 ± 10.5 | 0.579 | 0.001 | 0.498 |
Mean ± SD; * geometric mean (antiloged mean of the log data), in brackets-antilog of the log mean + log SD and log mean-log SD; BMI—body mass index; %FM—fat mass percentage; FM—fat mass; FFM—fat free mass; TBW—total body water; TC—total cholesterol; TGL—triglycerides; HDL-C—high density lipoprotein cholesterol, LDL-C—low density lipoprotein cholesterol; the level of statistical significance was set at p < 0.05.